HistoSonics Inc., a medical device company whose backers include Johnson & Johnson's venture capital arm, is considering a ...

Mike’s got more than 30 years’ experience in financial services,” says Pickerell. “He’s entrepreneurial and has good connections with clients. He’s been on our radar screen for some time.” Hong ...

Türkiye's startup ecosystem ended 2024 with 469 investment deals, totaling $1.1 billion (TL 39.23 billion), according to industry monitor data.

Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

Shares of weight-loss drug developer Metsera surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion. Shares of the company opened ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

The company launched the IPO after doubling revenue in 2024, driven by increased oil production from well acquisitions worth ...

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.

BloombergNEF says in a new report that global clean energy investment reached $2.1 trillion in 2024, more than doubling 2020 ...

Pimco, one of the world’s largest bond managers, owns 354 million Class A shares of Venture Global (VG), the natural-gas exporter that went ...

Shares in Venture Global are expected to make their debut on the New York Stock Exchange after the company raised $1.75 ...